Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Germline biallelic Mcm8 variants are associated with early-onset Lynch-like syndrome
Mariano Golubicki, … , Marina Antelo, Sergi Castellví-Bel
Mariano Golubicki, … , Marina Antelo, Sergi Castellví-Bel
Published August 25, 2020
Citation Information: JCI Insight. 2020;5(18):e140698. https://doi.org/10.1172/jci.insight.140698.
View: Text | PDF
Research Article Gastroenterology Genetics

Germline biallelic Mcm8 variants are associated with early-onset Lynch-like syndrome

  • Text
  • PDF
Abstract

Lynch syndrome is the most common cause of hereditary colorectal cancer (CRC), and it is characterized by DNA mismatch repair (MMR) deficiency. The term Lynch-like syndrome (LLS) is used for patients with MMR-deficient tumors and neither germline mutation in MLH1, MSH2, MSH6, PMS2, or EPCAM nor MLH1 somatic methylation. Biallelic somatic inactivation or cryptic germline MMR variants undetected during genetic testing have been proposed to be involved. Sixteen patients with early-onset LLS CRC were selected for germline and tumor whole-exome sequencing. Two potentially pathogenic germline MCM8 variants were detected in a male patient with LLS with fertility problems. A knockout cellular model for MCM8 was generated by CRISPR/Cas9 and detected genetic variants were produced by mutagenesis. DNA damage, microsatellite instability, and mutational signatures were monitored. DNA damage was evident for MCM8KO cells and the analyzed genetic variants. Microsatellite instability and mutational signatures in MCM8KO cells were compatible with the involvement of MCM8 in MMR. Replication in an independent familial cancer cohort detected additional carriers. Unexplained MMR-deficient CRC cases, even showing somatic biallelic MMR inactivation, may be caused by underlying germline defects in genes different than MMR genes. We suggest MCM8 as a gene involved in CRC germline predisposition with a recessive pattern of inheritance.

Authors

Mariano Golubicki, Laia Bonjoch, José G. Acuña-Ochoa, Marcos Díaz-Gay, Jenifer Muñoz, Miriam Cuatrecasas, Teresa Ocaña, Soledad Iseas, Guillermo Mendez, Daniel Cisterna, Stephanie A. Schubert, Maartje Nielsen, Tom van Wezel, Yael Goldberg, Eli Pikarsky, Juan Robbio, Enrique Roca, Antoni Castells, Francesc Balaguer, Marina Antelo, Sergi Castellví-Bel

×

Figure 8

Proposed molecular mechanism of pathogenicity for MCM8 variants.

Options: View larger image (or click on image) Download as PowerPoint
Proposed molecular mechanism of pathogenicity for MCM8 variants.
The MCM...
The MCM8/MCM9 hexameric complex is required for the MMR system and the HR-mediated DNA repair caused by ICL agents. Previous work has demonstrated that MCM9 interacts with the MMR proteins and is recruited to the mismatch lesion (16). Also, the MCM8/MCM9 complex is required for the MRN protein complex at DNA damage foci to facilitate DNA resection, a key step on DNA DSB repair (22). We propose that biallelic germline mutations in MCM8 affect the MCM8/MCM9 protein complex, impairing both DNA repair pathways and leading to the accumulation of noncorrected mutations. These alterations, in some cases, can also promote somatic biallelic MMR inactivation and LLS. CRC, colorectal cancer; DSBs, double-strand breaks; EO LLS, early-onset Lynch-like syndrome; HR, homologous recombination; ICL, interstrand cross-linking; MMR, mismatch repair.

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts